JamesStuartFerrissMDFACOG, FACS

PubMed

• 83 citations
  Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
  J. Stuart Ferriss, Young Chul Kim, Linda R. Duska, Michael J. Birrer, Douglas A. Levine
  Plos One. 2012-02-10
• 99 citations
  When 'never-events' occur despite adherence to clinical guidelines: the case of venous thromboembolism in clear cell cancer of the ovary compared with other epithelial...
  Linda R. Duska, Leslie A. Garrett, Melissa Henretta, J. Stuart Ferriss, Lisa Lee
  Gynecologic Oncology. 2010-03-01
• 264 citations
  Final overall survival of a randomized trial of bevacizumab for primary treatment of ovarian cancer
  Krishnansu S. Tewari, Robert A. Burger, Danielle Enserro, Barbara M. Norquist, Elizabeth M. Swisher
  Journal of Clinical Oncology. 2019-06-19

Books/Book Chapters

• Endometrial carcinoma. 
  Chapter: Clinical Gynecology 
  Hernandez E, Ferriss JSEditors: Beiber E, Sanfilippo J, Horowitz I, Shafi M.Cambridge University Press, Cambridge
• Early Diagnosis and Treatment of Cancer Series: Ovarian Cancer. 
  Chapter: Borderline Epithelial Ovarian Tumors, Sex Cord Stromal Tumors and Germ Cell Tumors of the Ovary 
  Ferriss JS, King E, Modesitt SCEditors: Bristow R, Armstrong D.Elsevier

Abstracts/Posters

• Blood Counts and Treatment Delay in African American Women Undergoing Chemotherapy for Gynecological Malignancy.
  Ridore A, Ferriss JS, Hernandez E, Mid-Atlantic Gynecologic Oncology Society, Ocean City, MD
• Gene Expression Ovarian Cancer.
  Ferriss JS, Kim YC, Duska L, Theodorescu D, Lee J, American Society of Clinical Oncology, Chicago, IL
• In vitro Model for Serous Carcinomas Arising in the Distal Fallopian Tube.
  Ferriss JS, Dalton S, Bryant J, Jazaeri A, Society of Gynecologic Oncologists, San Francisco, CA
• Extent of Cervical Involvement in Endometrial Cancer Predicts Survival.
  Ferriss JS, Brix W, Tambouret R, Desimone C, Stoler M, Modesitt SC, Society of Gynecologic Oncologists, San Francisco, CA
• The Role of Initial Chemotherapy for Ovarian Cancer in Setting of Significant Co-Morbidity.
  Ferriss JS, Ring K, King E, Rogers M, Mehtsun W, Duska L, Taylor P, Society of Gynecologic Oncologists, San Francisco, CA
• Extent of Cervical Involvement In Endometrical Cancer as a Predictor of Outcome.
  Ferriss JS, Brix W, Hanley K, Henretta M, Stoler M, Modesitt SC, ASCO Meeting Abstracts
• Grading of Small Biospy Samples of Ovarian Carcinoma: Relationship to Response to Neoadjuvant Chemotherapy.
  MT Galgano, KA Atkins, MH Stoler, Ferriss JS, EB Stelow, United States and Canadian Academy of Pathology, Boston, MA
• Cancer in Obese Women: The Potential Protective Impact of Bariatric Surgery.
  McCawley G, Ferriss JS, Northrup J, Modesitt S, Society of Gynecologic Oncologists Vol 112, Issue 2
• EV11 Isoforms Exhibit Different Effects on Growth and Apoptosis in Ovarian Cancer.
  Ferriss JS, Machida Y, Dalton S, Bryant J, Dutta A, Jazaeri A, Gynecologic Oncology, Volume 108, Issue 3, Supplement 1
• Temozolomide in the Treatment of Metastatic Leiomyosarcoma.
  Ferriss JS, Lachance J, Jazaeri A, The Mid- Atlantic Gynecologic Oncology Society, Baltimore, MD
• Join now to see all